Health Care Select Sector (XLV)

Latest stories mapped to XLV

Everything Newsig has mapped to XLV, newest first — no importance filter. Topic pages list critical and high-importance stories only.

• 2026-10-16 Viatris receives FDA approval for presbyopia treatment
• 2026-10-16 Novartis ends mid-stage trial for Fabhalta in lupus nephritis
• 2026-10-16 Viatris, Opus granted FDA label expansion for Ryzumvi in presbyopia
• 2026-10-16 FDA approves Opus Genetics’ eye drops for presbyopia treatment
• 2026-10-16 US FDA sets up board to oversee drug exclusivity determinations
• 2026-10-16 iRhythm wins new Overweight at Piper on YTD pullback
• 2026-10-16 Veracyte’s Prosigna breast cancer test receives Medicare coverage
• 2026-10-16 Sickle cell gene therapies offer new hope, but access remains a major challenge
• 2026-10-16 Factbox-Weight-loss drug developers line up to tap lucrative market as competition heats up
• 2026-10-16 Jefferies Highlights Top Mid-Cap Biotech Stocks Ahead of Earnings
• 2026-10-16 Roche's Enspryng wins FDA approval for thyroid eye disease
• 2026-10-16 FDA approves Enspryng for thyroid eye disease treatment
• 2026-10-15 US delays small imports rule that raised alarm over prescription drug costs
• 2026-10-15 Congo Ebola outbreak spreads to new province bordering Central African Republic
• 2026-10-15 Guardant Health loses challenge regarding DNA sequencing patent
• 2026-10-15 Big pharma stocks near all-time highs as tech selloff pushes investors toward safer bets
• 2026-10-15 Thermo Fisher Scientific stock hits all-time high at 694.33 USD
• 2026-10-15 Arcutis jumps as Cantor issues new Overweight citing lead product
• 2026-10-15 Eli Lilly's Omvoh boosted by new ulcerative colitis, Crohn's data
• 2026-10-15 GLP-1s are linked to lower psychiatric hospitalizations: study